Excessive chromium intake in children receiving total parenteral nutrition

A A Moukarzel1, M K Song, A L Buchman

  • 1Department of Pediatrics, UCLA School of Medicine.

Lancet (London, England)
|February 15, 1992
PubMed

Insights

The recommended chromium intake for children on total parenteral nutrition (TPN) may be too high. Studies show current levels are linked to reduced kidney function, even when intake is below recommendations, suggesting a need for lower chromium supplementation.

Area of Science:

  • Pediatric Nephrology
  • Nutritional Science
  • Clinical Chemistry

Background:

  • Expert bodies recommend 0.20 micrograms/kg/day of chromium for children on total parenteral nutrition (TPN).
  • Assessing the appropriateness of this recommended chromium intake is crucial for pediatric patient safety.
  • Previous studies have not fully evaluated chromium's impact on renal function in TPN-dependent children.

Purpose of the Study:

  • To evaluate the current recommended chromium intake for children receiving TPN.
  • To assess the relationship between chromium intake, serum chromium levels, and renal function (GFR) in these patients.
  • To determine if chromium supplementation in TPN solutions contributes to adverse renal effects.

Main Methods:

  • Studied 15 children receiving TPN, measuring chromium intake, serum chromium, and glomerular filtration rate (GFR) using indium-111-DTPA clearance.
  • Compared TPN patients' GFR and serum chromium to non-TPN controls.
  • Discontinued chromium supplementation and reassessed patients after one year to observe changes in GFR and serum chromium.

Main Results:

  • Children on TPN had significantly lower GFR (70 vs. 110 ml/min/1.73 m2) and 20-42 times higher serum chromium levels compared to controls.
  • GFR showed significant inverse correlations with serum chromium, daily chromium intake, cumulative intake, and TPN duration.
  • After discontinuing supplementation, serum chromium decreased, but GFR did not significantly change, and no chromium deficiency signs appeared.

Conclusions:

  • The recommended parenteral chromium intake for children receiving TPN may be excessive.
  • Elevated serum chromium levels, even below recommended intake, are associated with impaired renal function in TPN patients.
  • Lowering chromium supplementation in TPN solutions is warranted to prevent potential nephrotoxicity.

Related Concept Videos

Routes of Drug Administration: Enteral01:18

Routes of Drug Administration: Enteral

Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...